The study is limited by its retrospective design in which several variables such as medication groups, details on other liver conditions such as viral hepatitis, biomarkers of NAFLD severity (such as cytokeratin 18 fragment, interleukins, tissue necrosis factor) and genetic data were not collected. Here, KRT18 is linked to animal viral hepatitis.